Medgenics to Participate in the 2016 Canaccord Genuity Rare Disease, BioPharma One-On-One Day
January 26, 2016 08:30 ET
|
Medgenics, Inc.
PHILADELPHIA, Jan. 26, 2016 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), today announced that members of its management team will participate in the 2016 Canaccord Genuity Rare Disease,...
Medgenics Licenses Novel GeneRide Gene Therapy Technology From Stanford University
January 06, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN), today announced the signing of a license with Stanford University providing exclusive rights to certain breakthrough gene...
Medgenics Announces Annual Renewal of Rare and Orphan Disease Research Collaboration With The Children’s Hospital of Philadelphia
December 22, 2015 08:30 ET
|
Medgenics, Inc.
Annual option exercised to extend collaboration First development candidate advancing to Phase 2/3 development in 2016Additional programs expected in 2016 PHILADELPHIA, Dec. 22, 2015 (GLOBE...
Medgenics Announces Beta Thalassemia Research Program
December 16, 2015 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), today announced the initiation of a research program to evaluate the use of TARGTEPOTM alone or in combination with...
Medgenics to Present at 27th Annual Piper Jaffray Healthcare Conference
November 25, 2015 08:30 ET
|
Medgenics, Inc.
PHILADELPHIA, Nov. 25, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), today announced that Michael Cola, President and CEO, will participate in a fireside chat discussion at the 27th Annual...
Medgenics Reports Third Quarter 2015 Financial Results
October 22, 2015 08:00 ET
|
Medgenics, Inc.
Acquired Phase 2-Ready CNS asset, NFC-1
First of pipeline of potential programs from CHOP collaboration
Results of Phase 1 GREAT trial to be presented at American Academy of...
Medgenics to Host Conference Call to Announce Third Quarter 2015 Results on October 22, 2015
October 15, 2015 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Thursday, October 22, 2015 at 8:30 a.m. ET to discuss third quarter...
Medgenics Announces Key Appointments
October 13, 2015 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, Oct. 13, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced the following appointments:
Liza Squires, MD joins as Vice President Research and Development,...
Medgenics Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock
October 12, 2015 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced the completion of an underwritten public offering of 7,078,250 shares of its common stock, including...
Medgenics Prices Public Offering of Common Stock
October 01, 2015 09:01 ET
|
Medgenics, Inc.
PHILADELPHIA, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced the pricing of 6,155,000 shares of its common stock in a previously announced underwritten public...